BioWorld

May 31, 2002

Biotech Officials Push Harder To Get FDA Leader Appointed

WASHINGTON - Every now and then when a drug doesn't win FDA approval, someone in the background can be heard blaming the failure on a lack of leadership at the government agency. (BioWorld Today) Read More

Visible Genetics Considers Sale Of Company, Lowers Estimates

Nearly Complete Draft Of Mouse Genome Underlines Similarities To Human Genetic Complement

Agennix Raises $20M Privately, Prepares For Clinical Explosion

Other News To Note

Appointments And Advancements

Today's news in brief

BioWorld

BioWorld briefs for Dec. 10, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 10, 2025.

Epigenetic technology could eliminate misfolded prion proteins

BioWorld Science

The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

Brenig Therapeutics discovers new LRRK2 inhibitors

BioWorld Science

Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...